Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.

BACKGROUND & AIMS p38 mitogen-activated protein kinases are important inflammatory factors. p38α alteration has been implicated in both human and mouse inflammatory disease models. Therefore, we aimed to characterize the cell type-specific role of p38α in non-alcoholic steatohepatitis (NASH). METHODS Human liver tissues were obtained from 27 patients with non-alcoholic fatty liver disease (NAFLD) and 20 control individuals. NASH was established and compared between hepatocyte-specific p38α knockout (p38αΔHep), macrophage-specific p38α knockout (p38αΔMΦ) and wild-type (p38αfl/fl) mice fed with high-fat diet (HFD), high-fat/high-cholesterol diet (HFHC), or methionine-and choline-deficient diet (MCD). p38 inhibitors were administered to HFHC-fed wild-type mice for disease treatment. RESULTS p38α was significantly upregulated in the liver tissues of patients with NAFLD. Compared to p38αfl/fl littermates, p38αΔHep mice developed significant nutritional steatohepatitis induced by HFD, HFHC or MCD. Meanwhile, p38αΔMΦ mice exhibited less severe steatohepatitis and insulin resistance than p38αfl/fl mice in response to a HFHC or MCD. The effect of macrophage p38α in promoting steatohepatitis was mediated by the induction of pro-inflammatory factors (CXCL2, IL-1β, CXCL10 and IL-6) secreted by M1 macrophages and associated signaling pathways. p38αΔMΦ mice exhibited M2 anti-inflammatory polarization as demonstrated by increased CD45+F4/80+CD11b+CD206+ M2 macrophages and enhanced arginase activity in liver tissues. Primary hepatocytes from p38αΔMΦ mice showed decreased steatosis and inflammatory damage. In a co-culture system, p38α deleted macrophages attenuated steatohepatitic changes in hepatocytes through decreased secretion of pro-inflammatory cytokines (TNF-α, CXCL10 and IL-6), which mediate M1 macrophage polarization in p38αΔMΦ mice. Restoration of TNF-α, CXCL10 or IL-6 induced lipid accumulation and inflammatory responses in p38αfl/fl hepatocytes co-cultured with p38αΔMΦ macrophages. Moreover, pharmacological p38 inhibitors suppressed HFHC-induced steatohepatitis. CONCLUSIONS Macrophage p38α promotes the progression of steatohepatitis by inducing pro-inflammatory cytokine secretion and M1 polarization. p38 inhibition protects against steatohepatitis. LAY SUMMARY: p38 mitogen-activated protein kinases are important inflammatory factors. In the present study, we demonstrated that p38α is upregulated in liver tissues of patients with non-alcoholic fatty liver diseases. Genetic deletion of p38α in macrophages led to ameliorated nutritional steatohepatitis in mice through decreased pro-inflammatory cytokine secretion and increased M2 macrophage polarization.

• Publication year

  2019

• Venue

  Journal of Hepatology

• Publication date

  2019-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jhep.2019.03.014PMID 30914267
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation

  2018cited by this paper
• Deficiency of p38α in macrophage ameliorates d‐galactosamine/TNF‐α‐induced acute liver injury in mice

  2017cited by this paper
• Liver disease: Conscious uncoupling in NASH

  2017cited by this paper
• RORα Induces KLF4-Mediated M2 Polarization in the Liver Macrophages that Protect against Nonalcoholic Steatohepatitis.

  2017cited by this paper
• CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy.

  2016cited by this paper
• CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic Steatohepatitis

  2016cited by this paper
• Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advances

  2016cited by this paper
• Hepatic p38α regulates gluconeogenesis by suppressing AMPK.

  2015cited by this paper
• Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms

  2015cited by this paper
• TNF-a mediated inflammatory macrophage polarization contributes to the pathogenesis of steroid-induced osteonecrosis in mice

  2015cited by this paper
• Synthetic Phosphorylation of p38α Recapitulates Protein Kinase Activity

  2014cited by this paper
• Dual function of p38α MAPK in colon cancer: suppression of colitis-associated tumor initiation but requirement for cancer cell survival.

  2014cited by this paper
• CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis.

  2014cited by this paper
• Obesity, insulin resistance, NASH and hepatocellular carcinoma.

  2013cited by this paper
• CXCL10 contributes to p38-mediated apoptosis in primary T lymphocytes in vitro

  2012cited by this paper
• NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications

  2012cited by this paper
• Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

  2011cited by this paper
• Inactivation of p38 MAPK during liver regeneration.

  2011cited by this paper
• Body fat distribution and organ weights of 14 common strains and a 22-strain consomic panel of rats.

  2011cited by this paper
• Distinct effects of p38alpha deletion in myeloid lineage and gut epithelia in mouse models of inflammatory bowel disease.

  2010cited by this paper
• Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance

  2009cited by this paper
• Signalling pathways in alcohol-induced liver inflammation.

  2009cited by this paper
• Exploring the full spectrum of macrophage activation

  2008cited by this paper
• The kinase p38α serves cell type–specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression

  2008cited by this paper
• Macrophage Deletion of p38α Partially Impairs Lipopolysaccharide-Induced Cellular Activation1

  2008cited by this paper
• Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance.

  2008cited by this paper
• p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway

  2007cited by this paper
• BIRB796 Inhibits All p38 MAPK Isoforms in Vitro and in Vivo*

  2005cited by this paper
• JNK initiates a cytokine cascade that causes Pax2 expression and closure of the optic fissure.

  2003cited by this paper
• p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases

  2003cited by this paper
• p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system.

  2000cited by this paper

• Identification of shared oxidative stress related hub genes in NAFLD and atherosclerosis using bioinformatics and machine learning

  2026cites this paper
• The Role of Kupffer Cells and Liver Macrophages in the Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease

  2026cites this paper
• Integrating multi-omics and machine learning systematically deciphers cellular heterogeneity and fibrotic regulatory networks in the progression from MASLD to MASH

  2026cites this paper
• Sustainable Cultivation of Rare and Endangered Medicinal Plant Multicellular Spheroids Producing Bioactive Therapeutics for Alcohol-Related Liver Disease Therapy.

  2026cites this paper
• Glucolipid Metabolic Disorders and Helicobacter pylori Infection

  2026cites this paper
• Hepatocyte PLAGL2 deficiency alleviates MASH through MYD88-licensed inactivation of inflammasome.

  2026cites this paper
• Curcumin-Loaded Liposomes (hPLipo/Cur) with Liver-Targeting Properties for Efficient NAFLD Treatment by Alleviating Mitochondrial ROS-Mediated Ferroptosis via NRF2 Pathway.

  2026cites this paper
• Overexpression of SERPINA3 inhibits castration-resistant prostate cancer progression by enhancing M1 macrophage recruitment via CXCL2 upregulation

  2025cites this paper
• Umbilical Cord‐Mesenchymal Stromal Cell‐Derived Extracellular Vesicles Target the Liver to Improve Neurovascular Health in Type 2 Diabetes With Non‐Alcoholic Fatty Liver Disease

  2025cites this paper
• SAA1 deletion ameliorates cardiac injury after myocardial infarction by promoting macrophage transformation to reparative subtype.

  2025cites this paper
• TMAO promotes metabolic dysfunction-associated fatty liver disease (MAFLD) development through long-non coding RNA- highly upregulated liver cancer (HULC)

  2025cites this paper
• Associations of serum carotenoids with cardiovascular disease mortality among patients with metabolic dysfunction‐associated steatotic liver disease

  2025cites this paper
• Adipocyte MKK3 Increases in Human Obesity protecting against Insulin Resistance by p38β activation

  2025cites this paper
• Thyroid-Stimulating Hormone: An Important Target for the Prevention of Nonalcoholic Fatty Liver Disease

  2025cites this paper
• CiR-EIS alleviates metabolic dysfunction-associated steatohepatitis by modulating macrophage polarization involving the miR-548m/IGF1 axis.

  2025cites this paper
• Endogenous sulfur dioxide deficiency impairs bone regeneration through abolishing S-sulfenylating p38 at cysteine 211.

  2025cites this paper
• Macrophage polarization in cancer and beyond: from inflammatory signaling pathways to potential therapeutic strategies.

  2025cites this paper
• Aging and metabolic dysfunction-associated steatotic liver disease: a bidirectional relationship

  2025cites this paper
• Compound 3d Attenuates Metabolic Dysfunction-Associated Steatohepatitis via Peroxisome Proliferator-Activated Receptor Pathway Activation and Inhibition of Inflammatory and Apoptotic Signaling

  2025cites this paper
• Zwitterionic Brush‐Grafted Interfacial Bio‐Lubricant Evades Complement C3‐Mediated Macrophage Phagocytosis for Osteoarthritis Therapy

  2025cites this paper
• [Effects of liver fibrosis induced by iron overload on M2 polarization of macrophages in mice].

  2025cites this paper
• Deletion of Tfap2a in hepatocytes and macrophages promotes the progression of hepatocellular carcinoma by regulating SREBP1/FASN/ACC pathway and anti-inflammatory effect of IL10

  2025cites this paper
• Defining gastric cancer ecology: the crucial roles of TREM2+ macrophages and fibroblasts in tumor microenvironments

  2025cites this paper
• New insights into DEHP-induced inflammatory injury in chicken spleen: ROS/TLR4/MyD88 pathway and apoptosis/necroptosis-M1 polarization crosstalk

  2025cites this paper
• High glucose-induced alternative splicing of MEF2D in macrophages promotes vascular chronic inflammation in type 2 diabetes mellitus by mediating M1 macrophage polarization.

  2025cites this paper
• M6A Modified miR‐31‐5p Suppresses M1 Macrophage Polarization and Autoimmune Dry Eye by Targeting P2RX7

  2025cites this paper
• Hexokinase 2-mediated metabolic stress and inflammation burden of liver macrophages via histone lactylation in MASLD.

  2025cites this paper
• Liver diseases: epidemiology, causes, trends and predictions

  2025cites this paper
• Preparation of Morchella esculenta protein and its preventive effect on nonalcoholic fatty liver disease in mice.

  2025cites this paper
• Pharmacological treatment for metabolic dysfunction-associated steatotic liver disease and related disorders: Current and emerging therapeutic options.

  2025cites this paper
• Polydatin retards the progression of osteoarthritis by maintaining bone metabolicbalance and inhibiting macrophage polarization

  2025cites this paper
• Deficiency of hepatokine orosomucoid1 aggravates NAFLD progression in mice.

  2025cites this paper
• Exosome-equipped TNF antisense oligodeoxynucleotide or 2-deoxy-D-glucose ameliorated nonalcoholic steatohepatitis by modulating superoxide dismutase 1 in mice

  2025cites this paper
• Salidroside alleviates palmitic acid-induced hepatocyte injury by regulating the LILRB2-mediated autophagy pathway.

  2025cites this paper
• Immune activation induced by dysregulated lipid metabolism in the pathogenesis of type 2 diabetes

  2025cites this paper
• To Explore the Mechanism of Cuproptosis in Psoriasis Based on Bioinformatics and in vivo Experiments

  2025cites this paper
• Enhanced Bone Regeneration via Dual Immune-Modulatory Scaffold: Integrating Lipopolysaccharide/Gelatin Methacrylate and Proanthocyanidins/Polylactic Acid to Enhance Macrophage Recruitment and M2 Phenotype Polarization.

  2025cites this paper
• Sacubitril/Valsartan Attenuates Inflammation and Fibrosis Associated With Decreased Integrin α8 and Inhibits Hepatocarcinogenesis in a Rat Model of Metabolic Dysfunction-Associated Steatohepatitis.

  2025cites this paper
• From mechanisms to management: Early detection and improved treatment of MASLD and its related hepatocellular carcinoma

  2025cites this paper
• The inhibitory SAPS3–AMPK interaction detected in HEK293 cells is not detectable in muscle or liver from humans or mice

  2025cites this paper
• Tregs With High CD29 Expression Promote Cell Adhesion and Contribute to the Malignant Transformation of MASLD

  2025cites this paper
• Pathogenesis of metabolic dysfunction-associated steatotic liver disease and donor liver damage

  2025cites this paper
• Immune cell involvement in ulcer repair in radiation esophagitis and its role in the TGF-β1/p38MAPK/FN axis (Review)

  2025cites this paper
• Degenerating intervertebral discs in the streptozotocin-high-fat diet model of type 2 diabetes show extensive inflammation

  2025cites this paper
• Zebrafish model of palmitic acid induced MAFLD recapitulates pathways conserved in mice and humans

  2025cites this paper
• Cross-disease biomarker identification reveals shared diagnostic biomarkers for IVDD and NAFLD via bulk and single-cell RNA sequencing

  2025cites this paper
• Jianpi-Huayu-Jiedu formula improves metabolic dysfunction-associated steatohepatitis through ameliorateing hepatic oxidative stress and lipid accumulation in vivo and in vitro

  2025cites this paper
• The Dual Role of Macrophage Extracellular Traps in Host Defense and Disease: Mechanisms and Therapeutic Implications

  2025cites this paper
• Nicotinamide N-Methyltransferase in Non-Alcoholic Fatty Liver Disease: Mechanistic Insights and Emerging Therapeutic Strategies.

  2025cites this paper
• Chronic intermittent hypoxia exacerbates the progression of NAFLD via SPP1- mediated inflammatory polarization in macrophages.

  2025cites this paper
• Irradiated Tumor Cell-Released Microparticles Enhance the Therapeutic Efficacy of PD-1 Inhibitors by Promoting M1-TAMs Polarization in NSCLC Brain Metastases.

  2024cites this paper
• Inappropriate Diet Exacerbates Metabolic Dysfunction-Associated Steatotic Liver Disease via Abdominal Obesity

  2024cites this paper
• Key genes involved in nonalcoholic steatohepatitis improvement after bariatric surgery

  2024cites this paper
• CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer.

  2024cites this paper
• Novel insights into macrophage immunometabolism in nonalcoholic steatohepatitis.

  2024cites this paper
• Surfactant protein A promotes western diet-induced hepatic steatosis and fibrosis in mice

  2024cites this paper
• Elucidating the changes in the heterogeneity and function of radiation-induced cardiac macrophages using single-cell RNA sequencing

  2024cites this paper
• FGF21 ameliorates septic liver injury by restraining proinflammatory macrophages activation through the autophagy/HIF-1α axis

  2024cites this paper
• SLC7A11-ROS/αKG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression

  2024cites this paper
• Progranulin: A promising biomarker and therapeutic target for fibrotic diseases

  2024cites this paper
• Lack of p38 activation in T cells increases IL-35 and protects against obesity by promoting thermogenesis

  2024cites this paper
• Fatty acids promote M1 polarization of monocyte-derived macrophages in healthy or ketotic dairy cows and a bovine macrophage cell line via impairing mTOR-mediated autophagy.

  2024cites this paper
• LECT2 deletion exacerbates liver steatosis and macrophage infiltration in a male mouse model of LPS-mediated NASH.

  2024cites this paper
• Gossypetin targets the liver-brain axis to alleviate pre-existing liver fibrosis and hippocampal neuroinflammation in mice

  2024cites this paper
• Ferroptosis: principles and significance in health and disease

  2024cites this paper
• Reactive oxygen species regulation by NCF1 governs ferroptosis susceptibility of Kupffer cells to MASH.

  2024cites this paper
• The signaling pathways in obesity‐related complications

  2024cites this paper
• HDAC6 inhibitor ACY-1215 protects from nonalcoholic fatty liver disease via inhibiting CD14/TLR4/MyD88/MAPK/NFκB signal pathway

  2024cites this paper
• Molecular characteristics and immune microenvironment of gastrointestinal stromal tumours: targets for therapeutic strategies

  2024cites this paper
• Exploring the possible therapeutic mechanism of Danzhixiaoyao pills in depression and MAFLD based on "Homotherapy for heteropathy": A network pharmacology and molecular docking

  2024cites this paper
• The Multifaced Roles of Hepatic Macrophages in MASLD

  2024cites this paper
• Metabolic obesity phenotypes and the risk of cancer: a prospective study of the Kailuan cohort

  2024cites this paper
• Thermal ablation enhances immunotherapeutic effect of IP-001 on orthotopic liver cancer in a rat model

  2024cites this paper
• Progress in the Study of Animal Models of Metabolic Dysfunction-Associated Steatotic Liver Disease

  2024cites this paper
• Eravacycline improves the efficacy of anti-PD1 immunotherapy via AP1/CCL5 mediated M1 macrophage polarization in melanoma.

  2024cites this paper
• Deletion of p38 MAPK in macrophages ameliorates peritoneal fibrosis and inflammation in peritoneal dialysis

  2024cites this paper
• Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy

  2024cites this paper
• Tanshinone IIA Inhibits the Endoplasmic Reticulum Stress-Induced Unfolded Protein Response by Activating the PPARα/FGF21 Axis to Ameliorate Nonalcoholic Steatohepatitis

  2024cites this paper
• Role of Peptidyl arginine deiminase 4-dependent macrophage extracellular traps formation on Type 1 Diabetes pathogenesis.

  2024cites this paper
• Single‐cell sequencing combined with spatial transcriptomics reveals that the IRF7 gene in M1 macrophages inhibits the occurrence of pancreatic cancer by regulating lipid metabolism‐related mechanisms

  2024cites this paper
• The transcriptome and secreted factors of the intervertebral discs in STZ-HFD Type 2 diabetic male mice reveal extensive inflammation

  2024cites this paper
• Hub Genes Involved in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma.

  2024cites this paper
• CD274 (PD-L1) negatively regulates M1 macrophage polarization in ALI/ARDS

  2024cites this paper
• Traditional Chinese medicine in regulating macrophage polarization in immune response of inflammatory diseases.

  2024cites this paper
• Prepared Radix Polygoni Multiflori and emodin alleviate lipid droplet accumulation in nonalcoholic fatty liver disease through MAPK signaling pathway inhibition

  2024cites this paper
• Regulatory mechanism and therapeutic potentials of naringin against inflammatory disorders

  2024cites this paper
• Liver ACSM3 deficiency mediates metabolic syndrome via a lauric acid-HNF4α-p38 MAPK axis

  2024cites this paper
• Protective and Adverse Roles of DDX3X in Different Cell Types in Nonalcoholic Steatohepatitis Progression

  2023cites this paper
• Fructooligosaccharides attenuate non-alcoholic fatty liver disease by remodeling gut microbiota and association with lipid metabolism.

  2023cites this paper
• Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets.

  2023cites this paper
• Ang-(1–7)/MasR axis promotes functional recovery after spinal cord injury by regulating microglia/macrophage polarization

  2023cites this paper
• Vsig4^+ resident single-Kupffer cells improve hepatic inflammation and fibrosis in NASH

  2023cites this paper
• Phosphorus magnesium fiber regulates macrophage polarization through TRPM7 to accelerate wound healing

  2023cites this paper
• The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities

  2023cites this paper
• MLKL signaling regulates macrophage polarization in acute pancreatitis through CXCL10

  2023cites this paper
• Modified Signaling of Membrane Formyl Peptide Receptors in NADPH-Oxidase Regulation in Obesity-Resistant Mice

  2023cites this paper
• Metaflammation in glucolipid metabolic disorders: Pathogenesis and treatment.

  2023cites this paper
• Excess body weight: Novel insights into its roles in obesity comorbidities.

  2023cites this paper
• Myeloid-specific blockade of Notch signaling ameliorates nonalcoholic fatty liver disease in mice

  2023cites this paper
• Adipose Tissue Macrophage-Mediated Inflammation in Obesity: A Link to Posttranslational Modification

  2023cites this paper